Hyponatremia and Cancer: From Bedside to Benchside.
arginine vasopressin
cancer
hyponatremia
oxidative stress
syndrome of inappropriate antidiuresis
tolvaptan
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
13 Feb 2023
13 Feb 2023
Historique:
received:
03
01
2023
revised:
07
02
2023
accepted:
08
02
2023
entrez:
25
2
2023
pubmed:
26
2
2023
medline:
26
2
2023
Statut:
epublish
Résumé
Hyponatremia is the most common electrolyte disorder encountered in hospitalized patients. This applies also to cancer patients. Multiple causes can lead to hyponatremia, but most frequently this electrolyte disorder is due to the syndrome of inappropriate antidiuresis. In cancer patients, this syndrome is mostly secondary to ectopic secretion of arginine vasopressin by tumoral cells. In addition, several chemotherapeutic drugs induce the release of arginine vasopressin by the hypothalamus. There is evidence that hyponatremia is associated to a more negative outcome in several pathologies, including cancer. Many studies have demonstrated that in different cancer types, both progression-free survival and overall survival are negatively affected by hyponatremia, whereas the correction of serum [Na
Identifiants
pubmed: 36831539
pii: cancers15041197
doi: 10.3390/cancers15041197
pmc: PMC9953859
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
Eur J Endocrinol. 2022 Jun 07;187(1):209-217
pubmed: 35560282
J Cancer Res Ther. 2018 Jul-Sep;14(5):1049-1053
pubmed: 30197346
Am J Med. 2009 Jul;122(7):679-86
pubmed: 19559171
Best Pract Res Clin Endocrinol Metab. 2016 Mar;30(2):175-87
pubmed: 27156757
Am J Kidney Dis. 2016 Jun;67(6):893-901
pubmed: 26874645
Clin Med Insights Oncol. 2020 Jun 26;14:1179554920936605
pubmed: 32636693
Lancet. 2008 May 10;371(9624):1624-32
pubmed: 18468546
Osteoporos Int. 2002 Oct;13(10):777-87
pubmed: 12378366
Proc Natl Acad Sci U S A. 2017 Aug 8;114(32):E6603-E6612
pubmed: 28739902
PLoS One. 2016 May 11;11(5):e0152079
pubmed: 27167519
Eur J Cancer Care (Engl). 2015 Mar;24(2):224-31
pubmed: 24661476
Clin J Am Soc Nephrol. 2015 Dec 7;10(12):2268-78
pubmed: 26109207
Br J Cancer. 1993 Oct;68(4):767-74
pubmed: 8398705
Clin J Am Soc Nephrol. 2011 May;6(5):960-5
pubmed: 21441132
Am J Med. 2006 Jul;119(7 Suppl 1):S47-53
pubmed: 16843085
Nat Rev Gastroenterol Hepatol. 2019 Jul;16(7):411-428
pubmed: 31028350
Age (Dordr). 2013 Apr;35(2):271-88
pubmed: 22218780
Am J Med. 2020 Aug;133(8):986-993.e5
pubmed: 32145210
N Engl J Med. 2006 Nov 16;355(20):2099-112
pubmed: 17105757
Colorectal Dis. 2015 May;17(5):409-16
pubmed: 25524356
N Engl J Med. 2000 May 25;342(21):1581-9
pubmed: 10824078
Sci Rep. 2022 Jun 17;12(1):10266
pubmed: 35715573
Am J Kidney Dis. 2008 Jul;52(1):144-53
pubmed: 18468754
Clin Cancer Res. 2008 Mar 15;14(6):1775-81
pubmed: 18347179
Clin J Am Soc Nephrol. 2018 Mar 7;13(3):366-374
pubmed: 29439092
J Clin Invest. 1993 Dec;92(6):2653-9
pubmed: 8254021
J Clin Med. 2020 Apr 23;9(4):
pubmed: 32340364
Nat Rev Dis Primers. 2017 Mar 09;3:17009
pubmed: 28276433
Oncol Rev. 2017 May 09;11(1):321
pubmed: 28584570
Eur J Endocrinol. 2021 May 28;185(1):137-144
pubmed: 33950864
Clin Infect Dis. 2020 Jul 28;71(15):762-768
pubmed: 32161940
Am J Med. 2011 Jan;124(1):77-84
pubmed: 21187188
Arch Intern Med. 2010 Feb 8;170(3):294-302
pubmed: 20142578
J Am Soc Nephrol. 2006 Aug;17(8):2220-7
pubmed: 16807403
Hepatology. 2008 Sep;48(3):1002-10
pubmed: 18671303
Clin Endocrinol (Oxf). 2018 Oct;89(4):505-513
pubmed: 29920727
J Bone Miner Res. 2011 Aug;26(8):1822-8
pubmed: 21381111
J Am Soc Nephrol. 2002 Jun;13(6):1433-41
pubmed: 12039971
Korean J Pediatr. 2013 Dec;56(12):519-22
pubmed: 24416046
Clin Endocrinol (Oxf). 2019 Jun;90(6):842-848
pubmed: 30868608
J Bone Miner Res. 2010 Mar;25(3):554-63
pubmed: 19751154
Cancer Res. 1986 Aug;46(8):4189-94
pubmed: 3015384
BMC Cancer. 2015 Mar 22;15:163
pubmed: 25885450
Kidney Int. 2006 Jun;69(12):2124-30
pubmed: 16672911
Nat Med. 2003 Oct;9(10):1323-6
pubmed: 14502283
PLoS One. 2013 Dec 18;8(12):e80451
pubmed: 24367479
Mol Cell Endocrinol. 2021 Nov 1;537:111419
pubmed: 34389446
Gerontology. 2012;58(5):430-40
pubmed: 22722883
Eur Urol. 2014 Apr;65(4):723-30
pubmed: 24184025
Am J Med. 2013 Oct;126(10 Suppl 1):S1-42
pubmed: 24074529
J Intern Med. 1995 Aug;238(2):97-110
pubmed: 7629492
J Neurochem. 2000 Jul;75(1):304-13
pubmed: 10854275
Clin J Am Soc Nephrol. 2012 May;7(5):742-7
pubmed: 22403276
Eur J Intern Med. 2016 Dec;36:36-43
pubmed: 27527754
Cancers (Basel). 2020 May 07;12(5):
pubmed: 32392870
Support Care Cancer. 2007 Dec;15(12):1341-7
pubmed: 17701059
PLoS One. 2018 Mar 2;13(3):e0193857
pubmed: 29499058
Eur J Endocrinol. 2015 Jul;173(1):71-81
pubmed: 26036812
Int J Urol. 2012 Dec;19(12):1050-7
pubmed: 22860625
Clin Endocrinol (Oxf). 2019 May;90(5):744-752
pubmed: 30657193
Am J Med Sci. 2000 Apr;319(4):240-4
pubmed: 10768609
Cost Eff Resour Alloc. 2006 May 31;4:10
pubmed: 16737547
J Biol Chem. 2011 Mar 25;286(12):10864-75
pubmed: 21135109
Eur Urol. 2018 Apr;73(4):628-634
pubmed: 28807351
J Am Coll Cardiol. 2006 Dec 19;48(12):2397-409
pubmed: 17174176
J Cancer. 2019 Jan 29;10(4):836-842
pubmed: 30854089
Crit Rev Microbiol. 2022 Oct 20;:1-22
pubmed: 36264672
J Clin Invest. 1993 Jul;92(1):224-31
pubmed: 8392086
BMC Cancer. 2016 Jul 29;16:564
pubmed: 27473121
Bone. 2016 Mar;84:9-14
pubmed: 26679436
J Clin Endocrinol Metab. 2015 Aug;100(8):3021-31
pubmed: 26083821
J Am Soc Nephrol. 2008 Jan;19(1):102-8
pubmed: 18032793
Arch Surg. 2009 Jan;144(1):57-63; discussion 63
pubmed: 19153326
J Natl Compr Canc Netw. 2006 Jul;4(6):631-8
pubmed: 16813730
Eur J Intern Med. 2017 Jun;41:e25-e26
pubmed: 28215977
Jpn J Clin Oncol. 2011 Jan;41(1):148-52
pubmed: 21087977
Am J Physiol Renal Physiol. 2011 Nov;301(5):F1005-13
pubmed: 21816754
Oncol Ther. 2020 Jun;8(1):115-124
pubmed: 32700076
Rev Endocr Metab Disord. 2017 Mar;18(1):67-78
pubmed: 27664044
Mol Cancer Res. 2022 Aug 5;20(8):1295-1304
pubmed: 35503085
J Intern Med. 2018 Sep;284(3):270-281
pubmed: 29664160
J Cancer Res Ther. 2018 Jun;14(Supplement):S512-S515
pubmed: 29970716
Antioxid Redox Signal. 2004 Oct;6(5):878-87
pubmed: 15345148
PLoS One. 2015 Apr 23;10(4):e0124105
pubmed: 25905459
Oncogene. 2020 Feb;39(6):1231-1245
pubmed: 31616061
Anticancer Drugs. 2017 Jun;28(5):514-521
pubmed: 28225457
J Endocrinol Invest. 2022 Nov 27;:
pubmed: 36436190
Am J Med. 2013 Dec;126(12):1127-37.e1
pubmed: 24262726
J Endocrinol Invest. 2022 Sep;45(9):1693-1708
pubmed: 35604542
Nat Med. 2004 Apr;10(4):363-4
pubmed: 14991049
Neth J Med. 2020 Apr;78(3):125-131
pubmed: 32332187
Anticancer Res. 2014 Dec;34(12):7461-5
pubmed: 25503188
Eur J Endocrinol. 2014 Feb 25;170(3):G1-47
pubmed: 24569125
Endocrine. 2020 Feb;67(2):473-484
pubmed: 31784880
Cell Mol Life Sci. 2006 Aug;63(15):1766-79
pubmed: 16794787
Am J Med. 2009 Sep;122(9):857-65
pubmed: 19699382
Am J Med. 2006 Jan;119(1):71.e1-8
pubmed: 16431193
Br J Pharmacol. 1992 Apr;105(4):787-91
pubmed: 1387020
Biochem Pharmacol. 2015 Jun 15;95(4):324-36
pubmed: 25858412
Carcinogenesis. 2000 Mar;21(3):361-70
pubmed: 10688856
Support Care Cancer. 2015 Mar;23(3):621-6
pubmed: 25142706
Support Care Cancer. 2000 May;8(3):192-7
pubmed: 10789959
Am J Med. 2006 Jul;119(7 Suppl 1):S79-82
pubmed: 16843090
N Engl J Med. 2007 May 17;356(20):2064-72
pubmed: 17507705
J Pharmacol Exp Ther. 1997 Jul;282(1):301-8
pubmed: 9223568
QJM. 2008 Jul;101(7):583-8
pubmed: 18477645
Dig Dis Sci. 2021 May;66(5):1720-1729
pubmed: 32556820
Am J Dig Dis. 1976 Mar;21(3):249-56
pubmed: 1266841
Crit Rev Oncol Hematol. 2016 Jun;102:15-25
pubmed: 27066939
Clin J Am Soc Nephrol. 2010 Feb;5(2):275-80
pubmed: 20056759
Br J Cancer. 1990 Apr;61(4):597-604
pubmed: 2158808
Lung Cancer. 2010 Apr;68(1):111-4
pubmed: 19535164
Neuromolecular Med. 2013 Sep;15(3):493-503
pubmed: 23695860
Am J Kidney Dis. 2012 Feb;59(2):222-8
pubmed: 22001181
J Clin Endocrinol Metab. 1994 Oct;79(4):934-9
pubmed: 7962300
Front Mol Biosci. 2022 Sep 02;9:981963
pubmed: 36120538
BJOG. 2000 May;107(5):614-9
pubmed: 10826575
Acta Oncol. 2018 Nov;57(11):1580-1585
pubmed: 29863419
Curr Med Res Opin. 2015;31(9):1755-61
pubmed: 26173050
Lancet. 2020 Mar 28;395(10229):1033-1034
pubmed: 32192578
Am J Nephrol. 2007;27(2):184-90
pubmed: 17356253
Mol Cancer Ther. 2015 Jul;14(7):1582-90
pubmed: 25934709
Int Urol Nephrol. 2014 Nov;46(11):2153-65
pubmed: 25248629
Endocr J. 2017 Feb 27;64(2):235-236
pubmed: 28070057
Front Horm Res. 2019;52:161-166
pubmed: 32097904
Int J Cardiol. 2010 Jan 7;138(1):63-9
pubmed: 18789548
Biotechnol Adv. 2018 May - Jun;36(3):583-602
pubmed: 29339119
Oncologist. 2012;17(6):756-65
pubmed: 22618570
Med Hypotheses. 2012 Sep;79(3):327-8
pubmed: 22657915
J Pharmacol Exp Ther. 1998 Dec;287(3):860-7
pubmed: 9864265
J Stroke Cerebrovasc Dis. 2014 May-Jun;23(5):850-4
pubmed: 23954607
Med Res Rev. 1997 Jan;17(1):1-16
pubmed: 8979247
N Engl J Med. 2012 Dec 20;367(25):2407-18
pubmed: 23121377
Biochem Biophys Res Commun. 1994 Feb 28;199(1):353-60
pubmed: 8123034
Oncotarget. 2017 Apr 4;8(14):23871-23879
pubmed: 27863417
Sci Transl Med. 2019 Jun 26;11(498):
pubmed: 31243151
Front Med (Lausanne). 2021 Jun 14;8:666949
pubmed: 34195209
Int J Environ Res Public Health. 2017 Apr 26;14(5):
pubmed: 28445418